[1] |
LI Yating, YUE Hongmei, LIU Miaomiao, XU Jinhui, WU Xingdong, ZHU Haobin.
The possibility of phosphodiesterase 4 inhibitors as drug therapy for idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 818-823.
|
[2] |
WANG Xin, SUN Heliang, ZHANG Qingwei, LIU Cunming, WANG Zhongyun, YANG Chun.
Postoperative analgesic effect of low-dose esketamine in patients with thoracoscopic lobectomy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 998-1003.
|
[3] |
XING Bomin, GUO Na, NING Haihui, DING Xinyun, MA Yuqing.
Effects of Rho kinase inhibitors on septic liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 544-550.
|
[4] |
REN Yixing, LENG Yufang, GUO Mingjun, ZHANG Jianmin, SHI Yajing, CHEN Feng, LIU Xin.
Role and mechanism of SIRT3 in attenuation of intestinal ischemia-reperfusion injury by dexmedetomidine in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 253-259.
|
[5] |
LIU Peng, WANG Chen, WANG Yun, QIU Xinping.
Dioscin attenuates inflammatory injury in uric acid-induced renal tubular epithelial cells by suppression of NF-κB signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1099-1105.
|
[6] |
LI Hui, LI Jun, HUAN Suqin, LI Yuhong, FAN Jun.
Protection effect of dexmedetomidine against sepsis-induced intestinal mucosal barrier injury by up-regulating hypoxia inducible factor-1ɑ in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1386-1392.
|
[7] |
YANG Huifang, LUO Ying, ZHAO Li.
Effects of dexmedetomidine on renal function and serum inflammatory factors in sepsis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 857-861.
|
[8] |
RU Caiwang, YUAN Tianming, YANG Bingfen, WU Fugen, LIN Yingrong, MO Miaojun.
Effects of imipenem-cilastatin sodium combined with immunoglobulin on serum PCT, hs-CRP and TNF-α in children with baby sepsis complicated with disseminated intravascular coagulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 559-565.
|
[9] |
LU Yubao, CHEN Yutong, HE Gege, CAI Zongyan, CHENG Yue, CHENG Zihua, GUO Jiamin, GUO Yanzhi.
Application of traditional Chinese medicine extract in repairing spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1075-1080.
|
[10] |
RUAN Shuiliang,GUAN Qiaobing.
Mechanism of heat shock transcription factor 2 promotes inflammatory response in Crohn's disease through HMGB1-TLR4-NF-κB signaling
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 369-375.
|
[11] |
XUE Hua, LU Lili, XIANG Hui, QIAN Zhenhua.
Curative efficacy of ulinastatin combined with hydrocortisone in treatment of severe sepsis secondary shock and effects on serum factor levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 313-317.
|
[12] |
QIAO Yang, CHEN Qun, YANG Guang,CAO Yingya, LU Weihua.
iTRAQ technology based differences of protein expression in sepsis-associated encephalopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1269-1274.
|
[13] |
CAI Yun, XU Jinlong, ZHANG Mao.
Pharmacokinetic of piperacillin/tazobactam in patients with sepsis during continuous venovenous hemodiafiltration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 905-911.
|
[14] |
WEI Liuping, WU Qing, YIN Nange, YANG Bin, MAO Jinxiao.
Effect and safety of lactoferrin for prevention of late-onset sepsis in premature neonates: a systematic review
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 653-660.
|
[15] |
FANG Jingjing, TAO Jing, HUANG Qin, SHI Chaolu, YAN Biqing, GAI Lei, LI Xuguang.
Effects of platelet activation on renal tubular epithelial cells in sepsis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 283-289.
|